• Search
  • Search initialized

Category 1 Angiogenesis

 

Category 2 Atherosclerosis

 

Category 3 Vascular Functions

 

Category 4 Vascular Diseases

Category 5 Vascular Metabolism

 

Category 6 Lymphangiogenesis and Inflammation

 

Category 7 Technical Advances of Vascular Biology

 

Category 8 Others

1.1

Angiogenesis & Arteriogenesis

  • PO-102
  • A Novel Transmembrane Protein Tmem100: Regulatory Mechanisms of Endothelial-Specific Expression and Cellular Functions During Vascular Formation
  • Norika (Mengchia) LIU (National Cerebral and Cardiovascular Center Research Institute,Japan)
  • PO-104
  • Evaluation of the Impact of Peroxidasin On In Vitro and In Vivo Vessel Formation
  • Hong Seok Choi (College of Medicine, The Catholic University of Korea,Korea)
  • PO-105
  • Association Between Erythrocyte Dynamics and Vessel Remodelling in Developmental Vascular Networks
  • Miguel O. Bernabeu (The University of Edinburgh,UK)
  • PO-106
  • Inhibition of MEK1/2 Promotes Myocardial Arterialisation In Vivo
  • Elisa Avolio (University of Bristol,UK)
  • PO-107
  • Transdifferentiation of Human Adult Fibroblasts Into Authentic Endothelial Cells by Defined Factors
  • Youngchul Shin (Seoul National University Hospital,Korea)
  • PO-108
  • Endothelial Rho-GEF Trio Is Essential for Angiogenesis by Reorganizing the Actin Cytoskeleton via RhoG and Rac1
  • Lanette Kempers (Sanquin Research,Netherlands)
  • PO-109
  • Epithelial Vegfa Specifies a Distinct Endothelial Population in the Mouse Lung
  • Lisandra Vila Ellis (MD Anderson Cancer Center,USA)
  • PO-110
  • Establishment of a Cell Culture Model Derived From Human Corpus Cavernosum for In Vitro Erectile Function Study
  • Guo Nan Yin (Inha University Hospital, Inha University School of Medicine,Korea)
1.2

Angiogenic Mechanisms & Signaling

  • PO-111
  • Vasohibin-1 Inhibits Angiogenesis via the Increase of Detyrosinated α-Tubulin
  • Miho Kobayashi (Tokyo Medical and Dental University,Japan)
  • PO-112
  • Protrudin Regulates Angiogenesis
  • AMITA ARORA (Minerva Foundation Institute for Medical Research,Finland)
  • PO-114
  • LRG1-Dependent Angiogenesis Induced by IL6-STAT3 Signalling Axis
  • Athina Dritsoula (University College London, London,UK)
  • PO-115
  • Endothelial Toll-Like Receptor 2 Promotes Angiogenesis and Pro-Angiogenic Immune Cell Recruitment via Endogenous Ligand Signaling
  • Michael McCoy (Cleveland Clinic Foundation,USA)
  • PO-116
  • A Possible Biomechanical Mechanism Underlying Enhancement of Angiogenic Vessel Elongation by Pericytes
  • Yasuyuki Hanada (Nagoya University,Japan)
  • PO-117
  • Unc5b Is a Target of Notch Signaling and a Potential Effector of Notch-Mediated Vascular Barrier Enhancement
  • Qanber Raza (University of Illinois at Chicago,USA)
  • PO-118
  • The Chicken or the Egg: MSC-Endothelium Dialogue in 2d Angiogenesis Model
  • Irina Beloglazova (National Medical Research Center for Cardiology,Russian Federation)
  • PO-119
  • DIX Domain Containing 1(DIXDC1) Regulate VEGFR2 and Wnt/Beta-Catenin Signaling in Early Angiogenesis
  • Yeaji Kim (Yonsei University,Korea)
  • PO-120
  • Induction of Angiogenic Genes by Plasmodium Berghei Through Hypoxia-Induced Manner
  • Kyung-Yoon Jeon (Kosin University College of Medicine,Korea)
  • PO-121
  • Allin As Angiogenesis Inhibitor: Possible Mechanism of Action and Cost Effectiveness Perspective
  • Eka Nurdina Inayatussholeha (Universitas Islam Indonesia,Indonesia)
  • PO-122
  • Analysis of Rab5C/Vegfr2 Signaling During Sprouting Angiogenesis
  • Yuki Wakayama (Max Planck Institute for Molecular Biomedicine,Germany)
  • PO-123
  • VEGFR2-Nf2/Merlin Axis Governs Tip Cell Induction Depending on the Stability of Cell-Cell Contact
  • Jung Hyun Bae (KAIST,Korea)
  • PO-125
  • Regulation of BACH1/NRF2 by Hypoxia and the Impact on Adventitial Pericyte Function
  • Sadie Slater (University of Bristol,UK)
  • PO-126
  • Regulating Optimal Angiogenesis and Leukocyte Adhesion of Human Endothelial Cells by Gradient Nanopore Substrate
  • Soon Jun Hong (Korea University Anam Hospital,Korea)
  • PO-127
  • Target Identification and Validation of Voacangine Through a Systematic Combination of DARTS and MSI and Its New Derivative
  • Sung Min Cho (Yonsei University, Seoul 03722,Korea)
  • PO-128
  • Circulating miR-4435 as a Potential Biomarker of Colorectal Cancer Associated With UQCRB
  • Eunji Gwak (Yonsei University, Seoul 120-749,Korea)
  • PO-129
  • ALK2/ACVR1 Mediates BMP Signaling in Developmental and Pathological Angiogenesis
  • Boryeong Pak (Gwangju institute of Science and Technology,Korea)
  • PO-130
  • Regulation of Endothelial Cell Trafficking and Secretion of Soluble VEGFR1: Implications for Angiogenic Sprout Guidance
  • Karina Kinghorn (University of North Carolina at Chapel Hill,USA)
  • PO-131
  • Filopodia Speed Up Notch Lateral Inhibition Tip Cell Selection In Vivo and In Silico
  • Bahti Zakirov (Francis Crick Institute,UK)
  • PO-132
  • STAT3 Precedes HIF1alpha Transcriptional Responses to Oxygen and Oxygen and Glucose Deprivation in Human Brain Pericytes
  • Robert Carlsson (Scientist,Sweden)
  • PO-133
  • The Role of RUNX3 in Hypoxia-Induced Cell Proliferation and Antiapoptosis in Early Tumorigenesis
  • Ji-Hak Jeong (College of Pharmacy, Kyungpook National University,Korea)
1.4

Pathological and Therapeutic Angiogenesis

  • PO-134
  • Developmental Endothelium Specific Molecule (DESM) Regulates Angiogenesis and Tumor Progression
  • Yuri Miyamura (Kumamoto University,Japan)
  • PO-135
  • IGF Binding Protein 2 Augments Ischaemia-Induced Neovascularisation
  • Alexander-Francisco Bruns (University of Leeds,UK)
  • PO-136
  • Neutralizing Antibody to proNGF Rescues Erectile Function by Regulating the Expression of Neurotrophic and Angiogenic Factors in a Mouse Model of Cavernous Nerve Injury
  • Anita Limanjaya (Inha University School of Medicine,Korea)
  • PO-137
  • Thermostable Small Molecule Inhibitor of Angiogenesis and Vascular Permeability That Suppresses a pERK-FosB/ΔFosB-VCAM-1 Axis
  • Levon Khachigian (University of New South Wales,Australia)
  • PO-138
  • SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization
  • Songyi Seo (Chung-Ang university, college of pharmacy,Korea)
  • PO-139
  • Loss of Down Syndrome Critical Region (DSCR)-1 Leads Wound Healing-Dysregulation
  • Takahiro Manabe (Institute of Resource Development and analysis, Kumamoto University, Japan,Japan)
  • PO-140
  • Synergistic Effect of Adipose-Derived Stromal Cells and Dll4 Blockade on Fat Graft Retention
  • Il-Kug Kim (Yeungnam University College of Medicine,Korea)
  • PO-141
  • Desmoglein-2 Is a Novel Adhesion Molecule Important for Pancreatic Vasculature and the Development of Diabetes.
  • Claudine Bonder (University of South Australia & SA Pathology,Australia)
  • PO-142
  • MiR-93-5p in Systemic Lupus Erythematosus may Support Angiogenic Stability via Inhibition of EPAS1
  • Nicola Edwards (Manchester Metropolitan University,UK)
  • PO-143
  • Intracavernous Delivery of Dickkopf3 Gene or Peptide Rescues Erectile Function Through Enhanced Cavernous Angiogenesis in the Diabetic Mouse
  • Anita Limanjaya (Inha University,Korea)
1.5

Tumor Vessels and Therapeutics

  • PO-144
  • Wnt-Mediated Endothelial Transformation Into Mesenchymal Stem Cell-Like Cells Forms a Chemoresistant Vascular Niche in Glioblastoma
  • Yi Fan (University of Pennsylvania,USA)
  • PO-145
  • Conditioned Media Culture System Unveils an Intimate Crosstalk Between Head and Neck Cancer and Lymphatic Endothelial Cells
  • Jeon Yeob Jang (Ajou University School of Medicine,Korea)
  • PO-146
  • Exercise Improves Tumor Vasculature Function via S1P Receptor Signaling
  • Riccardo Ballarò (MD Anderson Cancer Center,USA)
  • PO-147
  • Focused Ultrasound-Driven Microbubbles (Sonoporation) Increases Doxorubicin Uptake in Tumor Xenografts by Enhancing Vascular Permeability
  • Sonia Hernandez (University of Chicago,USA)
  • PO-149
  • Novel Antiangiogenic Therapy Targeting Biglycan in Tumor Endothelial Cell Using Liposomal-siRNA Delivery System
  • Nako Maishi (Hokkaido University Graduate School of Dental Medicine,Japan)
  • PO-150
  • Increased ABCB1 Expression in Tumor Blood Vessels of Urothelial Carcinoma After Chemotherapy and Chemoresistance
  • Hiroshi Kikuchi (Hokkaido University Graduate School of Medicine,Japan)
  • PO-151
  • The Vascular Leakage Blocker Sac-1004modifies the Tumor Microenvironment and Enhances the Therapeutic Efficacy of ICB in Highly Immunogenic MC38 Tumor
  • Songyi Park (Yonsei university,Korea)
  • PO-152
  • The Role of LOX-1 in Tumor Endothelial Cells on Tumor Metastasis
  • Takuya Tsumita (Hokkaido University,Japan)
  • PO-153
  • Biglycan Deficiency Normalizes Tumor Blood Vessels and Potentiates Tumor Immune Responses
  • Cong Li (Hokkaido University,Japan)
  • PO-154
  • Modeling 3D Human Lymphatic Vasculature on High-Throughput Microfluidic Chip to Study Tumor Immune Microenvironment
  • Somin Lee (Seoul National University,Korea)
  • PO-155
  • Dynamic Changes of Tumor Blood Vessels in Tumors Resistant to Angiogenesis Inhibitors
  • Yumiko Hayashi (Osaka University,Japan)
  • PO-156
  • Novel Effects of the Latest Ultra-High Dose-Rate FLASH Radiotherapy on the Tumor Vasculature Through Decreased Myosin Light Chain Activation
  • Young-Eun Kim (Pohang University of Science and Technology,Korea)
  • PO-157
  • Blood Vessel Abnormality in Glioblastoma: Characterisation at Baseline, Recurrence and Following Radiotherapy Suggests a Therapy Induced Phenotype
  • Anastasia Widyadari (University of Leeds,UK)
  • PO-158
  • Desmoglein-2, an Unsuspected Regulator of Tumor Vasculature and Immune Response in Melanoma
  • Michaelia Cockshell (University of South Australia and SA Pathology,Australia)
  • PO-159
  • VEGF-Driven Vascular Abnormality in an Advanced GBM Mouse Model Generated by Somatic Mutations
  • Eunhyeong Lee (KAIST,Korea)
  • PO-160
  • -Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a VEGFR-2 Antagonist, Improves Anti-Tumor Activity by Increasing Its Stability Against Serum Peptidases
  • Taesam Kim (Kangwon uvniversity,Korea)
  • PO-161
  • Lack of Endothelial TGF-β Signaling Inhibits Tumor Angiogenesis In Vivo
  • Kako Hanada (Tokyo University of Pharmacy and Life Sciences,Japan)
  • PO-162
  • Arg-Leu-Tyr-Glu Inhibits Tumor Progression by Suppressing Angiogenesis via VEGFR-2 Antagonism
  • Wonjin Park (Kangwon national university,Korea)
  • PO-163
  • Immuno-Grab: Multi-Paratopic Decoy Receptor Targeting Tumor Microenvironment-Specific Angiogenic Factors
  • Kim Duk Ki (Korea Advanced Institute of Science and Technology (KAIST),Korea)
  • PO-164
  • Sizable Large-Volume Perfusable and Adaptable Microfluidic System to Decipher Tumor-Endothelium-Immune Cell Interactions
  • Yang Lin (Weill Cornell Medicine,USA)
  • PO-165
  • Tie2-Mediated Vascular Remodeling by Ferritin-Based Protein C Nanoparticles Confers Antitumor and Anti-Metastatic Activities
  • Hyeonha Jang (Kyungpook National University,Korea)
  • PO-166
  • The Role of Endothelial Cells in Immune/Inflammatory Responses Mediated Prostate Cancer Castration Resistance
  • Ji-Hak Jeong (College of Pharmacy, Kyungpook National University,Korea)